483
Oxalis LabsFDA 483 - Oxalis Labs - August 02, 2019
Record Details
Oxalis Labs, a drug manufacturer in Theda, India, was inspected by the FDA from July 29 to August 2, 2019. The inspection revealed significant issues with personnel adequacy for drug product processing and a failure to consistently investigate unexplained discrepancies, particularly regarding late stability sample testing. These observations indicate a lack of robust quality control and personnel management.
Open in Dashboard
ID · 8b9b4378-e8d2-4a71-aeca-bab25b566f94